Skip to content

13F-HR filed by ACUTA CAPITAL PARTNERS, LLC

ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 59 holding rows worth $612,269,000.

Accession
0001493152-18-006876
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 59 entries on the cover page, a total value of $612,269,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $612,269,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
IMMUNOMEDICS INC452907108COM5,850,000$85,469,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM4,260,000$71,994,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM1,115,000$54,791,000thousands by filing date
SPDR SER TR78464A870S&P BIOTECH500,000$43,866,000thousands by filing dateput
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR544,000$35,578,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR403,821$32,483,000thousands by filing date
iShares Russell 2000 ETF464287655SHS200,000$30,367,000thousands by filing dateput
CATALYST BIOSCIENCES INC14888D208COM1,154,722$29,792,000thousands by filing date
KADMON HLDGS INC48283N106COM5,950,000$25,288,000thousands by filing date
VERACYTE INC COM92337F107Stock3,318,000$18,448,000thousands by filing date
INTEC PHARMA LTD JERUSALEMM53644106SHS2,724,283$17,231,000thousands by filing date
CHEMBIO DIAGNOSTICS163572209COM2,006,667$16,053,000thousands by filing date
PowerShares QQQ Trust Unit Ser73935A104COM85,000$13,612,000thousands by filing dateput
ARROWHEAD PHARMACEUTICALS IN04280A100COM1,762,206$12,706,000thousands by filing date
Viewra, Inc92672L107COM1,852,878$11,914,000thousands by filing date
IRIDEX CORP462684101COM2,000,000$11,440,000thousands by filing date
ASSEMBLY BIOSCIENCES INC045396108COM155,000$7,617,000thousands by filing datecall
AVEXIS INC05366U100COM60,000$7,415,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW1,346,360$6,678,000thousands by filing date
CAS MED SYS INC124769209COM5,216,998$6,573,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM350,000$6,563,000thousands by filing date
Eli Lilly and Company532457108COM75,000$5,803,000thousands by filing dateput
ISHARES TR464287234MSCI EMG MKT ETF100,000$4,828,000thousands by filing dateput
ISHARES TR464287184CHINA LG-CAP ETF75,000$3,543,000thousands by filing dateput
CUTERA INC232109108COM70,000$3,518,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM203,300$3,436,000thousands by filing datecall
MIRATI THERAPEUTICS INC60468T105COM100,000$3,070,000thousands by filing date
FENNEC PHARMACEUTICALS INC31447P100COMMON STOCK250,000$3,024,000thousands by filing date
Armo Biosciences Inc04225U104COM80,000$2,993,000thousands by filing date
INOTEK PHARMACEUTICALS CORP45780VAB8NOTE 5.750% 8/03,000,000$2,871,000thousands by filing dateprincipal
NABRIVA THERAPEUTICS PLCG63637105SHS559,739$2,815,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock25,000$2,809,000thousands by filing dateput
VIVEVE MED INC92852W204COM NEW685,215$2,508,000thousands by filing date
EDITAS MEDICINE INC28106W103COM55,000$1,824,000thousands by filing dateput
AERIE PHARMACEUTICALS INC00771V108COM30,000$1,628,000thousands by filing datecall
ROCKWELL MED INC774374102COM305,000$1,589,000thousands by filing dateput
INTELLIA THERAPEUTICS INC45826J105COM75,000$1,582,000thousands by filing dateput
TRANSPORTATION & LOGISTI438083107COM79,000$1,477,000thousands by filing date
TWITTER INC90184L102COM50,000$1,451,000thousands by filing datecall
RA PHARMACEUTICALS INC74933V108COM270,000$1,434,000thousands by filing date
TESARO INC881569107COM25,000$1,429,000thousands by filing datecall
BIOTELEMETRY INC090672106COM40,000$1,242,000thousands by filing date
Accelerate Diagnostics00430H102COM50,000$1,143,000thousands by filing datecall
Ampio Pharmaceuticals03209T109COM325,000$1,105,000thousands by filing dateput
AMAG PHARMACEUTICALS INC00163U106COM50,000$1,008,000thousands by filing dateput
ALIMERA SCIENCES INC016259103COM974,318$1,004,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM50,000$950,000thousands by filing dateput
NUVECTRA CORP67075N108COM66,724$869,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM50,000$845,000thousands by filing dateput
ANI PHARMACEUTICALS INC00182C103COM14,300$833,000thousands by filing dateput
TWITTER INC90184L102COM25,000$725,000thousands by filing dateput
GLAUKOS CORP COM377322102Stock20,000$617,000thousands by filing dateput
AERIE PHARMACEUTICALS INC00771V108COM10,000$543,000thousands by filing dateput
CRISPR THERAPEUTICS AG NAMEN AKTH17182108Stock10,000$457,000thousands by filing dateput
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR25,000$427,000thousands by filing dateput
ENDO INTL PLCG30401106SHS60,000$356,000thousands by filing dateput
TRANSENTERIX INC89366M201COM NEW180,000$307,000thousands by filing dateput
MANNKIND CORP COM NEW56400P706Stock132,500$302,000thousands by filing dateput
ONCOBIOLOGICS INC68235M105COM29,082$26,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001493152-18-006876this filing2018-05-15acceptance time not in the bulk data set